Crook J - Search Results

1

Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526).

Crook J, Rodgers JP, Pisansky TM, Trabulsi EJ, Amin MB, Bice W, Morton G, Murtha AD, Vigneault E, Helou J, Michalski JM, Roach M 3rd, Beyer D, Jani AB, Horwitz EM, Raben A, Pugh S, Sandler H. Crook J, et al. Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1115-1122. doi: 10.1016/j.ijrobp.2021.10.138. Epub 2021 Nov 3. Int J Radiat Oncol Biol Phys. 2022. PMID: 34740768 Free PMC article. Clinical Trial.

2

Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant.

Mazeron JJ, Simon JM, Crook J, Calitchi E, Otmezguine Y, Le Bourgeois JP, Pierquin B. Mazeron JJ, et al. Among authors: crook j. Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1173-7. doi: 10.1016/0360-3016(91)90273-7. Int J Radiat Oncol Biol Phys. 1991. PMID: 1938515

3

Brachytherapy of neck metastases.

Choo R, Grimard L, Esche B, Crook J, Genest P, Odell P. Choo R, et al. Among authors: crook j. J Otolaryngol. 1993 Feb;22(1):54-7. J Otolaryngol. 1993. PMID: 7680385

4

Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.

Crook J, Robertson S, Collin G, Zaleski V, Esche B. Crook J, et al. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):31-7. doi: 10.1016/0360-3016(93)90418-u. Int J Radiat Oncol Biol Phys. 1993. PMID: 7690016

5

Proliferative cell nuclear antigen in postradiotherapy prostate biopsies.

Crook J, Robertson S, Esche B. Crook J, et al. Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):303-8. doi: 10.1016/0360-3016(94)90008-6. Int J Radiat Oncol Biol Phys. 1994. PMID: 7928458

6

Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma.

Crook JM, Bahadur YA, Robertson SJ, Perry GA, Esche BA. Crook JM, et al. Cancer. 1997 Jan 1;79(1):81-9. Cancer. 1997. PMID: 8988730

7

Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure.

Crook JM, Choan E, Perry GA, Robertson S, Esche BA. Crook JM, et al. Urology. 1998 Apr;51(4):566-72. doi: 10.1016/s0090-4295(97)00650-x. Urology. 1998. PMID: 9586608

8

Percent free prostate-specific antigen after radiotherapy for prostate cancer.

Crook JM, Bunting PS. Crook JM, et al. Urology. 1998 Jul;52(1):100-5. doi: 10.1016/s0090-4295(98)00119-8. Urology. 1998. PMID: 9671878

9

Effects of urethrography on prostate position: considerations for radiotherapy treatment planning of prostate carcinoma.

Malone S, Donker R, Broader M, Dahrouge S, Szanto J, Gerig L, Bociek G, Crook J. Malone S, et al. Among authors: crook j. Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):89-93. doi: 10.1016/s0360-3016(99)00425-3. Int J Radiat Oncol Biol Phys. 2000. PMID: 10656378 Clinical Trial.

10

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients.

Crook J, Malone S, Perry G, Bahadur Y, Robertson S, Abdolell M. Crook J, et al. Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):355-67. doi: 10.1016/s0360-3016(00)00637-4. Int J Radiat Oncol Biol Phys. 2000. PMID: 10974448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

742 results

Search Page

Filters